Loading...
The tyrosine-kinase inhibitor sunitinib targets vascular endothelial (VE)-cadherin: a marker of response to antitumoural treatment in metastatic renal cell carcinoma
BACKGROUND: Vascular endothelial (VE)-cadherin is an endothelial cell-specific protein responsible for endothelium integrity. Its adhesive properties are regulated by post-translational processing, such as tyrosine phosphorylation at site Y(685) in its cytoplasmic domain, and cleavage of its extrace...
Saved in:
| Published in: | Br J Cancer |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Nature Publishing Group UK
2018
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5943344/ https://ncbi.nlm.nih.gov/pubmed/29563634 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-018-0054-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|